ERCC1 and lung carcinoma: Researchers document changes of ERCC1 that contribute to this exceptional DNA repair signaling in cisplatin-resistant cancer cells that may actually make it possible to develop novel therapies for cisplatin-resistant lung cancer cancers [26].